| Dr David I Criss, MD | |
|
50 Rowe St, Ste 500, Melrose, MA 02176-3228 | |
| (781) 979-3800 | |
| (781) 662-2778 |
| Full Name | Dr David I Criss |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 34 Years |
| Location | 50 Rowe St, Melrose, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437135779 | NPI | - | NPPES |
| 3154319 | Medicaid | MA | |
| J14087 | Other | MA | BC/BS |
| 110122983 | Other | MA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 75982 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Home Health Of Haverhill | Lawrence, MA | Home health agency |
| All Care Vna-greater Lynn Inc | Lynn, MA | Home health agency |
| Partners Healthcare At Home - Home Care | Waltham, MA | Home health agency |
| Pathways Healthcare | Quincy, MA | Home health agency |
| Vna Care Network | Worcester, MA | Home health agency |
| Merrimack Valley Hospice, Inc | Lawrence, MA | Hospice |
| Melrosewakefield Healthcare | Melrose, MA | Hospital |
| Tufts Medical Center | Boston, MA | Hospital |
| Lowell General Hospital | Lowell, MA | Hospital |
| Winchester Hospital | Winchester, MA | Hospital |
| Lahey Hospital & Medical Center, Burlington | Burlington, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Melrose Internal Medicine Assoc Pc | 6901984897 | 3 |
News Archive
Today, the Association for Molecular Pathology (AMP) submitted written comments in response to the Request for Information made by the National Institutes of Health (NIH) for its Genetic Test Registry (GTR). AMP conducted a survey of its membership to formulate a comprehensive response to the RFI. "With the vast majority of respondents working in a clinical laboratory setting, AMP is able to inform the NIH on the general reaction to the GTR, including insight to the community's concerns and guidance to ensure the GTR is a valued resource," said Dr. Karen Mann, President of AMP.
New research from Rice University and Baylor College of Medicine shows analyzing the brains of stroke victims just days after the stroke allows researchers to link various speech functions to different parts of the brain, an important breakthrough that may lead to better treatment and recovery.
High levels of the stress hormone cortisol strongly predict cardiovascular death among both persons with and without pre-existing cardiovascular disease according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
In a study of more than 2,000 adults, researchers found that two MRI measurements of the abdominal aorta - the amount of plaque in the vessel and the thickness of its wall - are associated with future cardiovascular events, such as a heart attack or stroke. Results of the study are published online in the journal Radiology.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved the antidepressant Cymbalta (duloxetine HCl) for the treatment of generalized anxiety disorder (GAD), a condition that affects more than 6.5 million American adults in a given year.
› Verified 6 days ago
| Entity Name | Pratt Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275570319 PECOS PAC ID: 3375515661 Enrollment ID: O20040807000255 |
News Archive
Today, the Association for Molecular Pathology (AMP) submitted written comments in response to the Request for Information made by the National Institutes of Health (NIH) for its Genetic Test Registry (GTR). AMP conducted a survey of its membership to formulate a comprehensive response to the RFI. "With the vast majority of respondents working in a clinical laboratory setting, AMP is able to inform the NIH on the general reaction to the GTR, including insight to the community's concerns and guidance to ensure the GTR is a valued resource," said Dr. Karen Mann, President of AMP.
New research from Rice University and Baylor College of Medicine shows analyzing the brains of stroke victims just days after the stroke allows researchers to link various speech functions to different parts of the brain, an important breakthrough that may lead to better treatment and recovery.
High levels of the stress hormone cortisol strongly predict cardiovascular death among both persons with and without pre-existing cardiovascular disease according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
In a study of more than 2,000 adults, researchers found that two MRI measurements of the abdominal aorta - the amount of plaque in the vessel and the thickness of its wall - are associated with future cardiovascular events, such as a heart attack or stroke. Results of the study are published online in the journal Radiology.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved the antidepressant Cymbalta (duloxetine HCl) for the treatment of generalized anxiety disorder (GAD), a condition that affects more than 6.5 million American adults in a given year.
› Verified 6 days ago
| Entity Name | Melrose Internal Medicine Assoc Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629055538 PECOS PAC ID: 6901984897 Enrollment ID: O20080417000172 |
News Archive
Today, the Association for Molecular Pathology (AMP) submitted written comments in response to the Request for Information made by the National Institutes of Health (NIH) for its Genetic Test Registry (GTR). AMP conducted a survey of its membership to formulate a comprehensive response to the RFI. "With the vast majority of respondents working in a clinical laboratory setting, AMP is able to inform the NIH on the general reaction to the GTR, including insight to the community's concerns and guidance to ensure the GTR is a valued resource," said Dr. Karen Mann, President of AMP.
New research from Rice University and Baylor College of Medicine shows analyzing the brains of stroke victims just days after the stroke allows researchers to link various speech functions to different parts of the brain, an important breakthrough that may lead to better treatment and recovery.
High levels of the stress hormone cortisol strongly predict cardiovascular death among both persons with and without pre-existing cardiovascular disease according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
In a study of more than 2,000 adults, researchers found that two MRI measurements of the abdominal aorta - the amount of plaque in the vessel and the thickness of its wall - are associated with future cardiovascular events, such as a heart attack or stroke. Results of the study are published online in the journal Radiology.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved the antidepressant Cymbalta (duloxetine HCl) for the treatment of generalized anxiety disorder (GAD), a condition that affects more than 6.5 million American adults in a given year.
› Verified 6 days ago
| Entity Name | Cardiovascular Center At Tufts Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447764253 PECOS PAC ID: 3870857816 Enrollment ID: O20180430000179 |
News Archive
Today, the Association for Molecular Pathology (AMP) submitted written comments in response to the Request for Information made by the National Institutes of Health (NIH) for its Genetic Test Registry (GTR). AMP conducted a survey of its membership to formulate a comprehensive response to the RFI. "With the vast majority of respondents working in a clinical laboratory setting, AMP is able to inform the NIH on the general reaction to the GTR, including insight to the community's concerns and guidance to ensure the GTR is a valued resource," said Dr. Karen Mann, President of AMP.
New research from Rice University and Baylor College of Medicine shows analyzing the brains of stroke victims just days after the stroke allows researchers to link various speech functions to different parts of the brain, an important breakthrough that may lead to better treatment and recovery.
High levels of the stress hormone cortisol strongly predict cardiovascular death among both persons with and without pre-existing cardiovascular disease according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
In a study of more than 2,000 adults, researchers found that two MRI measurements of the abdominal aorta - the amount of plaque in the vessel and the thickness of its wall - are associated with future cardiovascular events, such as a heart attack or stroke. Results of the study are published online in the journal Radiology.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved the antidepressant Cymbalta (duloxetine HCl) for the treatment of generalized anxiety disorder (GAD), a condition that affects more than 6.5 million American adults in a given year.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David I Criss, MD 50 Rowe St, Ste 500, Melrose, MA 02176-3228 Ph: (781) 979-3800 | Dr David I Criss, MD 50 Rowe St, Ste 500, Melrose, MA 02176-3228 Ph: (781) 979-3800 |
News Archive
Today, the Association for Molecular Pathology (AMP) submitted written comments in response to the Request for Information made by the National Institutes of Health (NIH) for its Genetic Test Registry (GTR). AMP conducted a survey of its membership to formulate a comprehensive response to the RFI. "With the vast majority of respondents working in a clinical laboratory setting, AMP is able to inform the NIH on the general reaction to the GTR, including insight to the community's concerns and guidance to ensure the GTR is a valued resource," said Dr. Karen Mann, President of AMP.
New research from Rice University and Baylor College of Medicine shows analyzing the brains of stroke victims just days after the stroke allows researchers to link various speech functions to different parts of the brain, an important breakthrough that may lead to better treatment and recovery.
High levels of the stress hormone cortisol strongly predict cardiovascular death among both persons with and without pre-existing cardiovascular disease according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
In a study of more than 2,000 adults, researchers found that two MRI measurements of the abdominal aorta - the amount of plaque in the vessel and the thickness of its wall - are associated with future cardiovascular events, such as a heart attack or stroke. Results of the study are published online in the journal Radiology.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved the antidepressant Cymbalta (duloxetine HCl) for the treatment of generalized anxiety disorder (GAD), a condition that affects more than 6.5 million American adults in a given year.
› Verified 6 days ago
Fadel Bofarrag, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 585 Lebanon St, Melrose, MA 02176 Phone: 800-424-3672 Fax: 314-434-5939 | |
Prava Karki, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 585 Lebanon St, Melrose, MA 02176 Phone: 781-979-3000 | |
Mike H Summerer, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 585 Lebanon Street, Hallmark Health System, Melrose, MA 02176 Phone: 781-979-3342 | |
Mohender S Maan, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 585 Lebanon St, Melrose Wakefield Hospital, Melrose, MA 02176 Phone: 781-979-3000 | |
Dr. Erica L Brooks, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 50 Rowe St, Suite 600, Melrose, MA 02176 Phone: 781-979-3440 Fax: 781-979-0258 | |
Dr. Raj P. Shah, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 585 Lebanon St, Melrose, MA 02176 Phone: 860-305-6911 | |
Ronald P Sen, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 50 Tremont St, #109, Melrose, MA 02176 Phone: 781-662-3310 Fax: 781-662-6403 |